-transparent.png){kind=logo}
Continuous-flow isopycnic banding of rabies virus in sucrose gradient was used to purify the antigen for the preparation of a human diploid cell rabies vaccine. Prior to the addition of the stabilizer, the average specific potency of several vaccine batches was 234 antigenic values per 1.0 mg of protein. Further data regarding potency and stability of this vaccine are presented.
Related Publications
M Majer, and
J Hilfenhaus, and
H Gruschkau, and
R Mauler, and
W Hennessen
October 1980,
The Medical letter on drugs and therapeutics,
M Majer, and
J Hilfenhaus, and
H Gruschkau, and
R Mauler, and
W Hennessen
June 1977,
The Veterinary record,
M Majer, and
J Hilfenhaus, and
H Gruschkau, and
R Mauler, and
W Hennessen
March 1984,
Journal of the American Veterinary Medical Association,
M Majer, and
J Hilfenhaus, and
H Gruschkau, and
R Mauler, and
W Hennessen
February 1985,
Lancet (London, England),
M Majer, and
J Hilfenhaus, and
H Gruschkau, and
R Mauler, and
W Hennessen
January 2004,
Journal of travel medicine,
M Majer, and
J Hilfenhaus, and
H Gruschkau, and
R Mauler, and
W Hennessen
March 1974,
Applied microbiology,
M Majer, and
J Hilfenhaus, and
H Gruschkau, and
R Mauler, and
W Hennessen
January 1980,
JAMA,
M Majer, and
J Hilfenhaus, and
H Gruschkau, and
R Mauler, and
W Hennessen
December 1982,
JAMA,
M Majer, and
J Hilfenhaus, and
H Gruschkau, and
R Mauler, and
W Hennessen
May 1979,
Canadian Medical Association journal,
M Majer, and
J Hilfenhaus, and
H Gruschkau, and
R Mauler, and
W Hennessen
September 1979,
American journal of epidemiology,
